DEMENTIA, FRONTOTEMPORAL
Clinical trials for DEMENTIA, FRONTOTEMPORAL explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA, FRONTOTEMPORAL trials appear
Sign up with your email to follow new studies for DEMENTIA, FRONTOTEMPORAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain-Delivered gene therapy tested to halt devastating Early-Onset dementia
Disease control Recruiting nowThis early-phase study is testing a one-time gene therapy called AVB-101 for people with a specific genetic form of frontotemporal dementia (FTD-GRN). The therapy is designed to be delivered directly into the brain to restore a missing protein and potentially slow or stop disease…
Matched conditions: DEMENTIA, FRONTOTEMPORAL
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Brain injection aims to halt devastating dementia
Disease control Recruiting nowThis early-stage study is testing a one-time gene therapy called PBFT02 for adults with specific genetic forms of frontotemporal dementia (FTD). The therapy is delivered via a single injection into the spinal fluid, aiming to deliver a working copy of a missing or faulty gene to …
Matched conditions: DEMENTIA, FRONTOTEMPORAL
Phase: PHASE1, PHASE2 • Sponsor: Passage Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Can speaking two languages help protect the brain? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand if speech therapy tailored for bilingual people can help those with primary progressive aphasia, a condition that causes worsening language problems. Researchers will test 60 bilingual participants to see if practicing in both their languages improve…
Matched conditions: DEMENTIA, FRONTOTEMPORAL
Phase: NA • Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC